Volver a Agenda
Session Chair(s)
John Kamp
Washington Counsel
Coalition For Healthcare Communication (CHC), United States
Learning Objective : Discuss the First Amendment underpinnings of the IMS and Caronia court decisions including how those implicate the prescription marketing rules of the FDA; Recognize the importance of Citizen Petitions and other related actions by PhRMA, IWG and others; Identify the possible changes in FDA regulation likely in light of these rulings.
Speaker(s)
Physician Payment Sunshine: A Ray of Hope or a Deeply Flawed Law?
David Vulcano, MBA, RAC
HCA Healthcare | Society Clinical Research Sites, United States
Honorary President (SCRS); VP, Clinical Research Compliance and Integrity (HCA
Physician Payment Sunshine Act: Where Have We Gone and Where are We Going
Thomas Sullivan
Rockpointe Corporation, United States
President
The Sunshine Act's Impact on the Research Profession and Its Impact on Manufacturers That Sponsor Clinical Trials
Gary Shangold
Integurx Therapeutics LLC, United States
Chief Executive Officer
¿Tiene una cuenta?